Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation Combined with Camrelizumab in Advanced Intrahepatic Cholangiocarcinoma
NCT04299581Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Jul 2020
- Primary completion
- Dec 2025
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of camrelizumab in intrahepatic cholangiocarcinoma (ICC), sponsored by Fudan University. Started Jul 2020; status: recruiting.
02
Drugs
camrelizumab
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT04299581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04299581.